The subjective symptoms of patients being exploited on the questionnaire of Quality of Life EORTC-C30 LC-13 for lung cancer patients, assessed using the new criteria: median time to response was 2.3 ± 0.7 weeks, the rate of symptomatic improvement and median to deterioration (cough: 8.4 months; chest pain: 7.8 months; dyspnea: 7.3 months).